Calliditas Therapeutics has filed to raise $75 million in a U.S. IPO, although the final figure may differ. The firm is advancing a small pipeline of drug candidates focused on treating kidney and

View the latest market news and prices, and trading information. Market Cap $682.87M; Shares Outstanding 24 Calliditas Therapeutics AB provides pharmaceutical products for patients with

Köp aktien Calliditas Therapeutics AB - American Depositary Shares (CALT). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Director Market Access Commercial · New York. Calliditas, an ambitious pharmaceutical company is growing!

Earnings: 13-May (Est.) CALT Stock Summary and Trading Ideas (Calliditas Therapeutics Ab - American Depositary Shares | NASDAQ:CALT). 52 Weeks High, 27,05. 52 Weeks Low, 9,81. 52 Weeks %, 85,86. YTD %, -10,32.

Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for CALLIDITAS THERAPEUTICS AB Market Cap Market Cap.

CALT Market Cap as of today (March 26, 2021) is $702.66 Mil. In depth view into Calliditas Therapeutics AB Market Cap explanation, calculation, historical data and more 2021-03-10 2021-02-16 2021-03-31 Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden. It focuses on identifying, developing, and commercializing … Calliditas Therapeutics AB (publ) will today launch an investor roadshow for a contemplated initial public offering of American Depositary Shares in the United States for trading on The Nasdaq Global Market in the United States and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States. CALLIDITAS THERAPEUTICS ORD SHS-SEK-Equity-Company Index / Market info What's this? FTSE Index -Instrument market cap -Listing / Admission to trading .

(NASDAQ: CALT) Calliditas Therapeutics AB stock price per share is $28.36 today (as of Apr 23, 2021). What is Calliditas Therapeutics AB's Market Cap?

Find market predictions, CALTX financials and market news. 2 days ago Real-time trade and investing ideas on Calliditas Therapeutics CALT from the largest community of traders and investors. Get the latest Calliditas Therapeutics AB (CALTX) real-time quote, historical performance, charts, and other financial information to help you make more informed Learn about CALTX (XSTO) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Calliditas Therapeutics AB (CALT).

{{ chapter.num }}. {{ chapter.name }} C Security Systems · C-Rad · Cable Onda · Cadillac · CAG Group · Calliditas Cannabisbolag · Canon · Cantargia · Capacent Holding · Capio · CapMan Oyj Iran · Iran-konflikten · Irisity · Irlab · IRLAB Therapeutics · Irland · IRM · IRRAS Calliditas Therapeutics AB - The Swedish Life Science Calliditas börsen Tagged Calliditas Therapeutics och Abreos Biosciences » BioStock Stockwik Förvaltning, +5,09%. Serneke Group B, +3,52%. Vicore Pharma Holding, +2,91%.
Snälla ord

Calliditas Therapeutics AB is based in Stockholm, Sweden. Nasdaq Nordic Investor News Nasdaq Stockholm Welcomes Calliditas Therapeutics to the Main Market. Stockholm, June 29, 2018 — Nasdaq (Nasdaq: NDAQ) announces that Calliditas Therapeutics AB (short name: CALTX), a mid cap company within the health care sector, today will start trading of its shares on the main market of Nasdaq Stockholm.

2 Mar 2021 and enhancing liquidity in the stock), happened to coincide with a very turbulent spell in the stock market. Calliditas Therapeutics. 19 May 2020 Calliditas Therapeutics AB (publ) is looking to raise up to $75 million in its IPO company plans to list on the Nasdaq Global Market under the symbol CALT.
Got7 mark just right

2021-03-10

%. BVF Partners LP, 12,7, 12,7.

Seko pendelklubben

Name, Ticker, Mkt Cap £m, P/E (f), Yield % (f), Other Calliditas Therapeutics Ab · STO:CALTX, 541.6, Calliditas Therapeutics Ab Dividends · Calliditas

Use the PitchBook Platform to explore the full Get the latest Calliditas Therapeutics AB (CALTX) real-time quote, historical performance, charts, and other financial information to help you make more informed Latest Calliditas Therapeutics AB (CALTX:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. View today's stock price, news and analysis for Calliditas Therapeutics AB ADR ( CALT). Barron's also provides information on historical stock ratings, target Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutic Webull offers Calliditas Therapeutics AB (CALT) historical stock prices, in-depth market analysis, NASDAQ: CALT real-time stock quote data, in-depth charts, Calliditas Therapeutics Ab ADR stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Get Calliditas Therapeutics AB (CLTEF:OTCPK) real-time stock quotes, news, price and financial information from CNBC. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for CALLIDITAS THERAPEUTICS AB Market Cap Market Cap. In depth view into CALT (Calliditas Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. SEC CIK #0001795579 · – · Documents · Company Names & Stock Symbols · Where To Trade CALT · Latest USPTO Trademark Filings Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) Save the date: Calliditas to host a Capital Markets Day in Stockholm, Sweden, 5 Jun 2020 PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") offering on The Nasdaq Global Select Market by way of a capital increase of Calliditas Therapeutics AB ADR (CALT) Company Bio. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications.

Stock analysis for Calliditas Therapeutics AB (CALTX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View real-time stock prices and stock quotes for a full financial overview.

Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. Calliditas Therapeutics AB market cap as of February 16, 2021 is $0.77B. Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. 2020-08-04 2021-04-23 Market Cap: 5.713B: Beta (5Y Monthly) 1.53: PE Ratio (TTM) N/A: EPS (TTM)-9.66: Earnings Date: Feb 18, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 78.00 Market Cap is a widely used stock evaluation measure.